Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|March 23, 2010
Mechanism-based approaches to treating fragile XGül Dölen, Randall L Carpenter, Timothy D Ocain, et al.
Neurobiology of Learning and Memory|April 17, 2009
The levo enantiomer of amphetamine increases memory consolidation and gene expression in the hippocampus without producing locomotor stimulationKjesten A Wiig, Jonathan R Whitlock, Mel H Epstein, et al.
Psychopharmacology|April 14, 2011
Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndromeSurabi Veeraragavan, Nghiem Bui, Jennie R Perkins, et al.
Frontiers in Genetics|November 27, 2018
Validation of a Salivary RNA Test for Childhood Autism Spectrum DisorderSteven D Hicks, Alexander T Rajan, Kayla E Wagner, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 31, 2019
Saliva MicroRNA Differentiates Children With Autism From Peers With Typical and Atypical DevelopmentSteven D Hicks, Randall L Carpenter, Kayla E Wagner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2016
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 TrialJeremy Veenstra-VanderWeele, Edwin H Cook, Bryan H King, et al.
The Journal of Pain|March 18, 2005
Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trialDaniel M Paulson, Daniel T Kennedy, Roger A Donovick, et al.
Journal of Neurodevelopmental Disorders|June 16, 2017
Arbaclofen in fragile X syndrome: results of phase 3 trialsElizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, et al.
Journal of Neurodevelopmental Disorders|January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndromeKathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 3, 2023
Validation of the Observer-Reported Communication Ability (ORCA) measure for individuals with Rett syndromeBryce B Reeve, Nicole Lucas, Dandan Chen, et al.
Pageof 2